Chen, Z.; Rong, Y.; Ding, J.; Cheng, X.; Chen, X.; He, C.
Injectable Polypeptide Hydrogel Depots Containing Dual Immune Checkpoint Inhibitors and Doxorubicin for Improved Tumor Immunotherapy and Post-Surgical Tumor Treatment. Pharmaceutics 2023, 15, 428.
https://doi.org/10.3390/pharmaceutics15020428
AMA Style
Chen Z, Rong Y, Ding J, Cheng X, Chen X, He C.
Injectable Polypeptide Hydrogel Depots Containing Dual Immune Checkpoint Inhibitors and Doxorubicin for Improved Tumor Immunotherapy and Post-Surgical Tumor Treatment. Pharmaceutics. 2023; 15(2):428.
https://doi.org/10.3390/pharmaceutics15020428
Chicago/Turabian Style
Chen, Zhixiong, Yan Rong, Junfeng Ding, Xueliang Cheng, Xuesi Chen, and Chaoliang He.
2023. "Injectable Polypeptide Hydrogel Depots Containing Dual Immune Checkpoint Inhibitors and Doxorubicin for Improved Tumor Immunotherapy and Post-Surgical Tumor Treatment" Pharmaceutics 15, no. 2: 428.
https://doi.org/10.3390/pharmaceutics15020428
APA Style
Chen, Z., Rong, Y., Ding, J., Cheng, X., Chen, X., & He, C.
(2023). Injectable Polypeptide Hydrogel Depots Containing Dual Immune Checkpoint Inhibitors and Doxorubicin for Improved Tumor Immunotherapy and Post-Surgical Tumor Treatment. Pharmaceutics, 15(2), 428.
https://doi.org/10.3390/pharmaceutics15020428